Company news
OPKO Health, Inc. news in 2025
OPKO Health, Inc.'s news releases, calls and decks from 2025, newest first.
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 18, 2025
OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications
October 28, 2025
OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results
October 28, 2025
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers
October 27, 2025
OPKO Health to Report Third Quarter 2025 Financial Results on October 29
October 21, 2025
Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
September 15, 2025
OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results
July 30, 2025
OPKO Health to Report Second Quarter 2025 Financial Results on July 31
July 23, 2025
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress
July 7, 2025
OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium
June 24, 2025
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
June 24, 2025
OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development
June 8, 2025
OPKO Health to Participate in Two Upcoming Investor Conferences
May 14, 2025
OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results
April 29, 2025
OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025
April 16, 2025
OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program
April 3, 2025
OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
March 16, 2025
OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results
February 26, 2025
OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025
February 12, 2025
OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 8, 2025
OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck
January 6, 2025
Calls in 2025
Decks in 2025
- J.P. Morgan Healthcare Conference 2025
Conference · 12 slides · Jan 15, 2025